Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America

Heart Failure Society of America, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing

Research output: Contribution to journalArticle

Abstract

Type 2 diabetes mellitus is a risk factor for incident heart failure and increases the risk of morbidity and mortality in patients with established disease. Secular trends in the prevalence of diabetes mellitus and heart failure forecast a growing burden of disease and underscore the need for effective therapeutic strategies. Recent clinical trials have demonstrated the shared pathophysiology between diabetes mellitus and heart failure, the synergistic effect of managing both conditions, and the potential for diabetes mellitus therapies to modulate the risk of heart failure outcomes. This scientific statement on diabetes mellitus and heart failure summarizes the epidemiology, pathophysiology, and impact of diabetes mellitus and its control on outcomes in heart failure; reviews the approach to pharmacological therapy and lifestyle modification in patients with diabetes mellitus and heart failure; highlights the value of multidisciplinary interventions to improve clinical outcomes in this population; and outlines priorities for future research.

Original languageEnglish (US)
Pages (from-to)584-619
Number of pages36
JournalJournal of Cardiac Failure
Volume25
Issue number8
DOIs
StatePublished - Aug 1 2019

Fingerprint

Type 2 Diabetes Mellitus
Heart Failure
Diabetes Mellitus
Life Style
Epidemiology
Therapeutics
Clinical Trials
Pharmacology
Morbidity
Mortality
Population

Keywords

  • AHA Scientific Statement
  • Diabetes mellitus, type 2
  • Drug therapy
  • Heart failure
  • Lifestyle
  • Risk factors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Heart Failure Society of America, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, & Council on Cardiovascular and Stroke Nursing (2019). Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America. Journal of Cardiac Failure, 25(8), 584-619. https://doi.org/10.1016/j.cardfail.2019.05.007

Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America. / Heart Failure Society of America; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing.

In: Journal of Cardiac Failure, Vol. 25, No. 8, 01.08.2019, p. 584-619.

Research output: Contribution to journalArticle

Heart Failure Society of America, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology & Council on Cardiovascular and Stroke Nursing 2019, 'Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America', Journal of Cardiac Failure, vol. 25, no. 8, pp. 584-619. https://doi.org/10.1016/j.cardfail.2019.05.007
Heart Failure Society of America, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing. Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America. Journal of Cardiac Failure. 2019 Aug 1;25(8):584-619. https://doi.org/10.1016/j.cardfail.2019.05.007
Heart Failure Society of America ; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology ; Council on Cardiovascular and Stroke Nursing. / Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America. In: Journal of Cardiac Failure. 2019 ; Vol. 25, No. 8. pp. 584-619.
@article{193cc58a761f4301baea50dcb6c73468,
title = "Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America",
abstract = "Type 2 diabetes mellitus is a risk factor for incident heart failure and increases the risk of morbidity and mortality in patients with established disease. Secular trends in the prevalence of diabetes mellitus and heart failure forecast a growing burden of disease and underscore the need for effective therapeutic strategies. Recent clinical trials have demonstrated the shared pathophysiology between diabetes mellitus and heart failure, the synergistic effect of managing both conditions, and the potential for diabetes mellitus therapies to modulate the risk of heart failure outcomes. This scientific statement on diabetes mellitus and heart failure summarizes the epidemiology, pathophysiology, and impact of diabetes mellitus and its control on outcomes in heart failure; reviews the approach to pharmacological therapy and lifestyle modification in patients with diabetes mellitus and heart failure; highlights the value of multidisciplinary interventions to improve clinical outcomes in this population; and outlines priorities for future research.",
keywords = "AHA Scientific Statement, Diabetes mellitus, type 2, Drug therapy, Heart failure, Lifestyle, Risk factors",
author = "{Heart Failure Society of America} and {American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology} and {Council on Cardiovascular and Stroke Nursing} and Dunlay, {Shannon M.} and Givertz, {Michael M.} and D. Aguilar and Allen, {Larry A.} and Michael Chan and Desai, {Akshay S.} and A. Deswal and Dickson, {Victoria Vaughan} and Kosiborod, {Mikhail N.} and Lekavich, {Carolyn L.} and McCoy, {Rozalina G.} and Mentz, {Robert J.} and Pina, {Ileana L.}",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.cardfail.2019.05.007",
language = "English (US)",
volume = "25",
pages = "584--619",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Churchill Livingstone",
number = "8",

}

TY - JOUR

T1 - Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America

AU - Heart Failure Society of America

AU - American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology

AU - Council on Cardiovascular and Stroke Nursing

AU - Dunlay, Shannon M.

AU - Givertz, Michael M.

AU - Aguilar, D.

AU - Allen, Larry A.

AU - Chan, Michael

AU - Desai, Akshay S.

AU - Deswal, A.

AU - Dickson, Victoria Vaughan

AU - Kosiborod, Mikhail N.

AU - Lekavich, Carolyn L.

AU - McCoy, Rozalina G.

AU - Mentz, Robert J.

AU - Pina, Ileana L.

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Type 2 diabetes mellitus is a risk factor for incident heart failure and increases the risk of morbidity and mortality in patients with established disease. Secular trends in the prevalence of diabetes mellitus and heart failure forecast a growing burden of disease and underscore the need for effective therapeutic strategies. Recent clinical trials have demonstrated the shared pathophysiology between diabetes mellitus and heart failure, the synergistic effect of managing both conditions, and the potential for diabetes mellitus therapies to modulate the risk of heart failure outcomes. This scientific statement on diabetes mellitus and heart failure summarizes the epidemiology, pathophysiology, and impact of diabetes mellitus and its control on outcomes in heart failure; reviews the approach to pharmacological therapy and lifestyle modification in patients with diabetes mellitus and heart failure; highlights the value of multidisciplinary interventions to improve clinical outcomes in this population; and outlines priorities for future research.

AB - Type 2 diabetes mellitus is a risk factor for incident heart failure and increases the risk of morbidity and mortality in patients with established disease. Secular trends in the prevalence of diabetes mellitus and heart failure forecast a growing burden of disease and underscore the need for effective therapeutic strategies. Recent clinical trials have demonstrated the shared pathophysiology between diabetes mellitus and heart failure, the synergistic effect of managing both conditions, and the potential for diabetes mellitus therapies to modulate the risk of heart failure outcomes. This scientific statement on diabetes mellitus and heart failure summarizes the epidemiology, pathophysiology, and impact of diabetes mellitus and its control on outcomes in heart failure; reviews the approach to pharmacological therapy and lifestyle modification in patients with diabetes mellitus and heart failure; highlights the value of multidisciplinary interventions to improve clinical outcomes in this population; and outlines priorities for future research.

KW - AHA Scientific Statement

KW - Diabetes mellitus, type 2

KW - Drug therapy

KW - Heart failure

KW - Lifestyle

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=85070222492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070222492&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2019.05.007

DO - 10.1016/j.cardfail.2019.05.007

M3 - Article

VL - 25

SP - 584

EP - 619

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

SN - 1071-9164

IS - 8

ER -